Covidien Ltd. (NYSE: COV; BSX: COV) today held its first Annual
General Meeting as an independent, publicly held company. Two
proposals were on the meeting agenda:
-0-
*T
-- Election of Directors, and
-- Appointment of Independent Auditors.
*T
At the meeting, shareholders elected all 11 nominees, each of whom
currently serves on Covidien´s Board of Directors. They are: Craig
Arnold, Robert H. Brust, John M. Connors, Jr., Christopher J.
Coughlin, Timothy M. Donahue, Kathy J. Herbert, Randall J. Hogan, III,
Richard J. Meelia, Dennis H. Reilley, Tadataka Yamada, and Joseph A.
Zaccagnino.
Shareholders also approved the appointment of Deloitte & Touche
LLP to serve as the Company´s independent auditors.
ABOUT COVIDIEN LTD.
Covidien is a leading global healthcare products company that
creates innovative medical solutions for better patient outcomes and
delivers value through clinical leadership and excellence. Covidien
manufactures, distributes and services a diverse range of
industry-leading product lines in four segments: Medical Devices,
Imaging Solutions, Pharmaceutical Products and Medical Supplies. With
2007 revenue of nearly $9 billion, Covidien has more than 43,000
employees worldwide in 57 countries, and its products are sold in over
130 countries. Please visit www.covidien.com to learn more about our
business.
